Montreal Heart Institute announces COLCORONA trial in patients with COVID-19 passes futility test in interim analysis

NEXT STORY
Cell Publication Elucidates How SARS-CoV-2 Dramatically Rewires Important Cell Programming; Identifies Existing Therapeutics That May Fight COVID-19
PREV STORY
Kessler Topaz Meltzer & Check, LLP:  Securities Fraud Class Action Filed Against Chembio Diagnostics, Inc. – CEMI
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Global Clinical Microbiology Instruments and Reagents Market to Reach $6.1 Billion by 2027

author_avatar
NASDAQ Market News

Preliminary results for the year ended 31 December 2020

author_avatar
NASDAQ Market News

Repros Announces Submission of MAA to the European Medicines Agency for Enclomiphene in the Treatment of Secondary Hypogonadism

UK designated as rapporteur and France as co-rapporteurAverage time to approval 13 – 16 ...

author_avatar
NASDAQ Market News